glp-1 and keto Beyond Agonists: An Adaptive Ketogenic–Mediterranean Protocol to Counter Metabolic Adaptation in Obesity Management GLP-1 users on low-carb or

McCarty's study involved a meta-analysis of 36 randomized controlled trials, assessing the effect of GLP-1 agonists on gastric emptying for over 1,500 patients

Physiol Rev, 70:987-1028

Compounded medicine is an important part of our healthcare system

Only medications included in the CMS demonstration are covered

Insulin resistance & prediabetes, National Institute of Diabetes and Digestive and Kidney Diseases (2025) Efficacy and safety of once-weekly semaglutide 2.4 mg versus placebo in people with obesity and prediabetes (STEP 10): a randomised, double-blind, placebo-controlled, multicentre phase 3 trial, The Lancet Diabetes & Endocrinology (2024) With prediabetes, action is the best medicine, American Diabetes Association Prevention or Delay of Diabetes and Associated Comorbidities: Standards of Care in Diabetes2025, Diabetes Care (2025) About the Lifestyle Change Program, CDC (2024)